{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011140","form_type":"8-K","ticker":"TGTX","cik":"0001001316","company_name":"TG THERAPEUTICS, INC.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.519213+00:00","generated_at":"2026-06-13T23:32:16.470190+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"TG Therapeutics shareholders reject say-on-pay and share increase at annual meeting","bullets":["Advisory say-on-pay failed: 26.0M For (37.4%) vs 43.5M Against (62.6%).","Proposal to increase authorized shares from 175M to 200M failed; 69.9M For but not majority of outstanding 149.4M shares.","Only directors Michael Weiss (75.8%) and Laurence Charney (66.1%) received majority for; others <60%.","Ratification of KPMG as auditor approved with 102.3M For (99.8% of votes cast)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011140","json":"https://secwatch.observer/filing/0001558370-23-011140.json","markdown":"https://secwatch.observer/filing/0001558370-23-011140.md","text":"https://secwatch.observer/filing/0001558370-23-011140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/0001558370-23-011140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/tgtx-20230614x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:32:16.470190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}